{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T20:28:38Z","timestamp":1791664118498,"version":"4.3.4"},"reference-count":106,"publisher":"Pleiades Publishing Ltd","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochemistry Moscow"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1134\/s0006297924110130","type":"journal-article","created":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T17:28:04Z","timestamp":1733506084000},"page":"1998-2022","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Role of MMP-2 and MMP-9 in the Relationship between Inflammation, Fibrosis, and Apoptosis during Progression of Non-Alcoholic Fatty Liver Disease and Diagnostic Significance of Plasma Levels of Their Active Forms"],"prefix":"10.1134","volume":"89","author":[{"given":"Irina V.","family":"Kurbatova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyudmila V.","family":"Topchieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga P.","family":"Dudanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia A.","family":"Shipovskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"137","published-online":{"date-parts":[[2024,12,6]]},"reference":[{"key":"2774_CR1","doi-asserted-by":"publisher","first-page":"216","DOI":"10.26442\/00403660.2022.02.201363","volume":"94","author":"M. V. Maevskaya","year":"2022","unstructured":"Maevskaya, M. V., Kotovskaya, Yu. V., Ivashkin, V. T., Tkacheva, O. N., Troshina, E. A., Shestakova, M. V., Breder, V. V., Geivandova, N. I., Doshchitsin, V. L., Dudinskaya, E. N., Ershova, E. V., Kodzoeva, Kh. B., Konshilova, K. A., Korochanskaya, N. V., Mayorov, A. Yu., Mishina, E. E., Nadinskaya, M. Yu., Nikitin, I. G., Pogosova, N. V., Tarzimanova, A. I., and Shakhmalova, M. Sh. (2022) The National Consensus statement on the management of adult patients with non-alcoholic fatty liver disease and main comorbidities, Ter. Arkh, 94, 216-253, \nhttps:\/\/doi.org\/10.26442\/00403660.2022.02.201363.","journal-title":"Ter. Arkh"},{"key":"2774_CR2","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1016\/j.cgh.2021.12.002","volume":"20","author":"M. H. Le","year":"2022","unstructured":"Le, M. H., Yeo, Y. H., Li, X., Li, J., Zou, B., Wu, Y., Ye, Q., Huang, D. Q., Zhao, C., Zhang, J., Liu, C., Chang, N., Xing, F., Yan, S., Wan, Z. H., Tang, N. S. Y., Mayumi, M., Liu, X., Liu, C., Rui, F., Yang, H., Yang, Y., Jin, R., Le, R. H. X., Xu, Y., Le, D. M., Barnett, S., Stave, C. D., Cheung, R., Zhu, Q., and Nguyen, M. H. (2022) 2019\u00a0global NAFLD prevalence: a systematic review and meta-analysis, Clin. Gastroenterol. Hepatol., 20, 2809-2817.e28, \nhttps:\/\/doi.org\/10.1016\/j.cgh.2021.12.002.","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"2774_CR3","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","volume":"77","author":"Z. M. Younossi","year":"2023","unstructured":"Younossi, Z. M., Golabi, P., Paik, J. M., Henry, A., Van Dongen, C., and Henry, L. (2023) The\u00a0global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review, Hepatology, 77, 1335-1347, \nhttps:\/\/doi.org\/10.1097\/HEP.0000000000000004.","journal-title":"Hepatology"},{"key":"2774_CR4","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","volume":"7","author":"K. Riazi","year":"2022","unstructured":"Riazi, K., Azhari, H., Charette, J. H., Underwood, F. E., King, J. A., Afshar, E. E., Swain, M. G., Congly, S. E., Kaplan, G. G., and Shaheen, A. A. (2022) The\u00a0prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis, Lancet Gastroenterol. Hepatol., 7, 851-861, \nhttps:\/\/doi.org\/10.1016\/S2468-1253(22)00165-0.","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"2774_CR5","doi-asserted-by":"publisher","first-page":"313","DOI":"10.26442\/20751753.2023.5.202155","volume":"25","author":"I. V. Maev","year":"2023","unstructured":"Maev, I. V., Andreev, D. N., and Kucheryavyy, Yu. A. (2023) Prevalence of non-alcoholic fat disease liver in Russian Federation: meta-analysis [in Russian], Consilium Medicum, 25, 313-319, \nhttps:\/\/doi.org\/10.26442\/20751753.2023.5.202155.","journal-title":"Consilium Medicum"},{"key":"2774_CR6","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1146\/annurev-pathol-020117-043617","volume":"13","author":"J. P. Arab","year":"2018","unstructured":"Arab, J. P., Arrese, M., and Trauner, M. (2018) Recent insights into the pathogenesis of nonalcoholic fatty liver disease, Annu. Rev. Pathol., 13, 321-350, \nhttps:\/\/doi.org\/10.1146\/annurev-pathol-020117-043617.","journal-title":"Annu. Rev. Pathol."},{"key":"2774_CR7","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/hep4.1479","volume":"4","author":"G. Parthasarathy","year":"2020","unstructured":"Parthasarathy, G., Revelo, X., and Malhi, H. (2020) Pathogenesis of nonalcoholic steatohepatitis: an overview, Hepatol. Commun., 4, 478-492, \nhttps:\/\/doi.org\/10.1002\/hep4.1479.","journal-title":"Hepatol. Commun."},{"key":"2774_CR8","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","volume":"184","author":"R. Loomba","year":"2021","unstructured":"Loomba, R., Friedman, S. L., and Shulman, G. I. (2021) Mechanisms and disease consequences of nonalcoholic fatty liver disease, Cell, 184, 2537-2564, \nhttps:\/\/doi.org\/10.1016\/j.cell.2021.04.015.","journal-title":"Cell"},{"key":"2774_CR9","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3350\/cmh.2022.0237","volume":"29","author":"K. C. Lee","year":"2023","unstructured":"Lee, K. C., Wu, P. S., and Lin, H. C. (2023) Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis, Clin. Mol. Hepatol., 29, 77-98, \nhttps:\/\/doi.org\/10.3350\/cmh.2022.0237.","journal-title":"Clin. Mol. Hepatol."},{"key":"2774_CR10","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1002\/hep.24001","volume":"52","author":"H. Tilg","year":"2010","unstructured":"Tilg, H., and Moschen, A. R. (2010) Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis, Hepatology, 52, 1836-1846, \nhttps:\/\/doi.org\/10.1002\/hep.24001.","journal-title":"Hepatology"},{"key":"2774_CR11","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","volume":"65","author":"E. Buzzetti","year":"2016","unstructured":"Buzzetti, E., Pinzani, M., and Tsochatzis, E. A. (2016) The\u00a0multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD), Metabolism, 65, 1038-1048, \nhttps:\/\/doi.org\/10.1016\/j.metabol.2015.12.012.","journal-title":"Metabolism"},{"key":"2774_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222011128","volume":"22","author":"S. Ziolkowska","year":"2021","unstructured":"Ziolkowska, S., Binienda, A., Jab\u0142kowski, M., Szemraj, J., and Czarny, P. (2021) The\u00a0interplay between insulin resistance, inflammation, oxidative stress, base excision repair and metabolic syndrome in nonalcoholic fatty liver disease, Int.\u00a0J. Mol. Sci., 22, 11128, \nhttps:\/\/doi.org\/10.3390\/ijms222011128.","journal-title":"Int.\u00a0J. Mol. Sci."},{"key":"2774_CR13","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1053\/j.gastro.2013.11.049","volume":"146","author":"J. E. Lambert","year":"2014","unstructured":"Lambert, J. E., Ramos-Roman, M. A., Browning, J. D., and Parks, E.\u00a0J. (2014) Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease, Gastroenterology, 146, 726-735, \nhttps:\/\/doi.org\/10.1053\/j.gastro.2013.11.049.","journal-title":"Gastroenterology"},{"key":"2774_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/biom12060824","volume":"12","author":"F. Nassir","year":"2022","unstructured":"Nassir, F. (2022) NAFLD: Mechanisms, treatments, and biomarkers, Biomolecules, 12, 824, \nhttps:\/\/doi.org\/10.3390\/biom12060824.","journal-title":"Biomolecules"},{"key":"2774_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21113863","volume":"21","author":"H. Fujii","year":"2020","unstructured":"Fujii, H., Kawada, N., and Japan Study Group of Nafld Jsg-Nafld (2020) The\u00a0role of insulin resistance and diabetes in nonalcoholic fatty liver disease, Int.\u00a0J. Mol. Sci., 21, 3863, \nhttps:\/\/doi.org\/10.3390\/ijms21113863.","journal-title":"Int.\u00a0J. Mol. Sci."},{"key":"2774_CR16","doi-asserted-by":"publisher","first-page":"6184","DOI":"10.3390\/ijms15046184","volume":"15","author":"U. J. Jung","year":"2014","unstructured":"Jung, U. J., and Choi, M. S. (2014) Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease, Int.\u00a0J. Mol. Sci., 15, 6184-6223, \nhttps:\/\/doi.org\/10.3390\/ijms15046184.","journal-title":"Int.\u00a0J. Mol. Sci."},{"key":"2774_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/nu11081712","volume":"11","author":"Y. Ji","year":"2019","unstructured":"Ji, Y., Yin, Y., Li, Z., and Zhang, W. (2019) Gut microbiota-derived components and metabolites in the progression of non-alcoholic fatty liver disease (NAFLD), Nutrients, 11, 1712, \nhttps:\/\/doi.org\/10.3390\/nu11081712.","journal-title":"Nutrients"},{"key":"2774_CR18","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.ecl.2023.01.003","volume":"52","author":"S. D. Anwar","year":"2023","unstructured":"Anwar, S. D., Foster, C., and Ashraf, A. (2023) Lipid disorders and metabolic-associated fatty liver disease, Endocrinol. Metab. Clin. North Am., 52, 445-457, \nhttps:\/\/doi.org\/10.1016\/j.ecl.2023.01.003.","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"2774_CR19","doi-asserted-by":"publisher","first-page":"104","DOI":"10.22416\/1382-4376-2022-32-4-104-140","volume":"32","author":"V. T. Ivashkin","year":"2022","unstructured":"Ivashkin, V. T., Maevskaya, M. V., Zharkova, M. S., Kotovskaya, Yu. V., Tkacheva, O. N., Troshina, E. A., Shestakova, M. V., Maev, I. V., Breder, V. V., Geivandova, N. I., Doshchitsin, V. L., Dudinskaya, E. N., Ershova, E. V., Kodzoeva, Kh. B., Komshilova, K. A., Korochanskaya, N. V., Mayorov, A. Yu., Mishina, E. E., Nadinskaya, M. Yu., Nikitin, I. G., Pogosova, N. V., Tarzimanova, A. I., and Shamkhalova, M. Sh. (2022) Clinical Practice Guidelines of the Russian Scientific Liver Society, Russian Gastroen- terological Association, Russian Association of Endocrinologists, Russian Association of Gerontologists and Geriatricians and National Society for Preventive Cardiology on Di- agnosis and Treatment of Non-Alcoholic Liver Disease, Russ. J. Gastroenterology, Hepatology, Coloproctology, 32, 104-140, \nhttps:\/\/doi.org\/10.22416\/1382-4376-2022-32-4-104-140.","journal-title":"Russ. J. Gastroenterology, Hepatology, Coloproctology"},{"key":"2774_CR20","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","volume":"397","author":"E. E. Powell","year":"2021","unstructured":"Powell, E. E., Wong, V. W., and Rinella, M. (2021) Non-alcoholic fatty liver disease, Lancet, 397, 2212-2224, \nhttps:\/\/doi.org\/10.1016\/S0140-6736(20)32511-3.","journal-title":"Lancet"},{"key":"2774_CR21","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","volume":"149","author":"P. Angulo","year":"2015","unstructured":"Angulo, P., Kleiner, D. E., Dam-Larsen, S., Adams, L. A., Bjornsson, E. S., Charatcharoenwitthaya, P., Mills, P. R., Keach, J. C., Lafferty, H. D., Stahler, A., Haflidadottir, S., and Bendtsen, F. (2015) Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease, Gastroenterology, 149, 389-397.e10, \nhttps:\/\/doi.org\/10.1053\/j.gastro.2015.04.043.","journal-title":"Gastroenterology"},{"key":"2774_CR22","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1053\/j.gastro.2005.03.084","volume":"128","author":"V. Ratziu","year":"2005","unstructured":"Ratziu, V., Charlotte, F., Heurtier, A., Gombert, S., Giral, P., Bruckert, E., Grimaldi, A., Capron, F., and Poynard, T., and LIDO Study Group (2005) Sampling variability of liver biopsy in nonalcoholic fatty liver disease, Gastroenterology, 128, 1898-1906, \nhttps:\/\/doi.org\/10.1053\/j.gastro.2005.03.084.","journal-title":"Gastroenterology"},{"key":"2774_CR23","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s11739-023-03203-0","volume":"18","author":"P. Portincasa","year":"2023","unstructured":"Portincasa, P. (2023) NAFLD, MAFLD, and beyond: one or several acronyms for better comprehension and patient care, Intern. Emerg. Med., 18, 993-1006, \nhttps:\/\/doi.org\/10.1007\/s11739-023-03203-0.","journal-title":"Intern. Emerg. Med."},{"key":"2774_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/medicines6010041","volume":"6","author":"U. Iqbal","year":"2019","unstructured":"Iqbal, U., Perumpail, B. J., Akhtar, D., Kim, D., and Ahmed, A. (2019) The\u00a0epidemiology, risk profiling and diagnostic challenges of nonalcoholic fatty liver disease, Medicines (Basel), 6, 41, \nhttps:\/\/doi.org\/10.3390\/medicines6010041.","journal-title":"Medicines (Basel)"},{"key":"2774_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2022.100765","volume":"27","author":"D. Garc\u00eda-Compe\u00e1n","year":"2022","unstructured":"Garc\u00eda-Compe\u00e1n, D., and Jim\u00e9nez-Rodr\u00edguez, A. R. (2022) NAFLD VS MAFLD. The\u00a0evidence-based debate has come. Time to change? Ann. Hepatol., 27, 100765, \nhttps:\/\/doi.org\/10.1016\/j.aohep.2022.100765.","journal-title":"Ann. Hepatol."},{"key":"2774_CR26","doi-asserted-by":"publisher","first-page":"329","DOI":"10.14218\/JCTH.2021.00178","volume":"10","author":"E. Kaya","year":"2022","unstructured":"Kaya, E., and Yilmaz, Y. (2022) Metabolic-associated fatty liver disease (MAFLD): a multi-systemic disease beyond the liver, J.\u00a0Clin. Transl. Hepatol., 10, 329-338, \nhttps:\/\/doi.org\/10.14218\/JCTH.2021.00178.","journal-title":"J.\u00a0Clin. Transl. Hepatol."},{"key":"2774_CR27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.mam.2018.09.002","volume":"65","author":"M. Parola","year":"2019","unstructured":"Parola, M., and Pinzani, M. (2019) Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues, Mol. Aspects Med., 65, 37-55, \nhttps:\/\/doi.org\/10.1016\/j.mam.2018.09.002.","journal-title":"Mol. Aspects Med."},{"key":"2774_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.addr.2017.05.016","volume":"121","author":"K. B\u00f6ttcher","year":"2017","unstructured":"B\u00f6ttcher, K., and Pinzani, M. (2017) Pathophysiology of liver fibrosis and the methodological barriers to the development of anti-fibrogenic agents, Adv. Drug Deliv. Rev., 121, 3-8, \nhttps:\/\/doi.org\/10.1016\/j.addr.2017.05.016.","journal-title":"Adv. Drug Deliv. Rev."},{"key":"2774_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/cells9051212","volume":"9","author":"E. Geervliet","year":"2020","unstructured":"Geervliet, E., and Bansal, R. (2020) Matrix metalloproteinases as potential biomarkers and therapeutic targets in liver diseases, Cells, 9, 1212, \nhttps:\/\/doi.org\/10.3390\/cells9051212.","journal-title":"Cells"},{"key":"2774_CR30","doi-asserted-by":"publisher","first-page":"9448","DOI":"10.1073\/pnas.1201840109","volume":"109","author":"T. Kisseleva","year":"2012","unstructured":"Kisseleva, T., Cong, M., Paik, Y., Scholten, D., Jiang, C., Benner, C., Iwaisako, K., Moore-Morris, T., Scott, B., Tsukamoto, H., Evans, S. M., Dillmann, W., Glass, C. K., and Brenner, D. A. (2012) Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis, Proc. Natl. Acad. Sci. USA, 109, 9448-9453, \nhttps:\/\/doi.org\/10.1073\/pnas.1201840109.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2774_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/cells9040875","volume":"9","author":"N. Roehlen","year":"2020","unstructured":"Roehlen, N., Crouchet, E., and Baumert, T. F. (2020) Liver fibrosis: mechanistic concepts and therapeutic perspectives, Cells, 9, 875, \nhttps:\/\/doi.org\/10.3390\/cells9040875.","journal-title":"Cells"},{"key":"2774_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2023.1183808","volume":"10","author":"Y. Q. Zhao","year":"2023","unstructured":"Zhao, Y. Q., Deng, X. W., Xu, G. Q., Lin, J., Lu, H. Z., and Chen, J. (2023) Mechanical homeostasis imbalance in hepatic stellate cells activation and hepatic fibrosis, Front. Mol. Biosci., 10, 1183808, \nhttps:\/\/doi.org\/10.3389\/fmolb.2023.1183808.","journal-title":"Front. Mol. Biosci."},{"key":"2774_CR33","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s43152-021-00030-3","volume":"2","author":"C. Ortiz","year":"2021","unstructured":"Ortiz, C., Schierwagen, R., Schaefer, L., Klein, S., Trepat, X., and Trebicka, J. (2021) Extracellular matrix remodeling in chronic liver disease, Curr. Tissue Microenviron. Rep., 2, 41-52, \nhttps:\/\/doi.org\/10.1007\/s43152-021-00030-3.","journal-title":"Curr. Tissue Microenviron. Rep."},{"key":"2774_CR34","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1242\/dmm.012062","volume":"7","author":"M. Giannandrea","year":"2014","unstructured":"Giannandrea, M., and Parks, W. C. (2014) Diverse functions of matrix metalloproteinases during fibrosis, Dis. Model Mech., 7, 193-203, \nhttps:\/\/doi.org\/10.1242\/dmm.012062.","journal-title":"Dis. Model Mech."},{"key":"2774_CR35","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.bbadis.2012.11.002","volume":"7","author":"J. P. Iredale","year":"2013","unstructured":"Iredale, J. P., Thompson, A., and Henderson, N. C. (2013) Extracellular matrix degradation in liver fibrosis: biochemistry and regulation, Biochim. Biophys. Acta, 7, 876-883, \nhttps:\/\/doi.org\/10.1016\/j.bbadis.2012.11.002.","journal-title":"Biochim. Biophys. Acta"},{"key":"2774_CR36","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.matbio.2017.12.012","volume":"68-69","author":"E. Roeb","year":"2018","unstructured":"Roeb, E. (2018) Matrix metalloproteinases and liver fibrosis (translational aspects), Matrix Biol., 68-69, 463-473, \nhttps:\/\/doi.org\/10.1016\/j.matbio.2017.12.012.","journal-title":"Matrix Biol."},{"key":"2774_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2022.174910","volume":"923","author":"A. R. Alshanwani","year":"2022","unstructured":"Alshanwani, A. R., Hagar, H., Shaheen, S., Alhusaini, A. M., Arafah, M. M., Faddah, L. M., Alharbi, F. M., Sharma, A. K., Fayed, A., and Badr, A.\u00a0M. (2022) A\u00a0promising antifibrotic drug, pyridoxamine attenuates thioacetamide-induced liver fibrosis by combating oxidative stress, advanced glycation end products, and balancing matrix metalloproteinases, Eur.\u00a0J. Pharmacol., 923, 174910, \nhttps:\/\/doi.org\/10.1016\/j.ejphar.2022.174910.","journal-title":"Eur.\u00a0J. Pharmacol."},{"key":"2774_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114472","volume":"161","author":"L. Shan","year":"2023","unstructured":"Shan, L., Wang, F., Zhai, D., Meng, X., Liu, J., and Lv, X. (2023) Matrix metalloproteinases induce extracellular matrix degradation through various pathways to alleviate hepatic fibrosis, Biomed. Pharmacother., 161, 114472, \nhttps:\/\/doi.org\/10.1016\/j.biopha.2023.114472.","journal-title":"Biomed. Pharmacother."},{"key":"2774_CR39","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1007\/s10620-010-1296-0","volume":"56","author":"B. D. Radbill","year":"2011","unstructured":"Radbill, B. D., Gupta, R., Ramirez, M. C. M., DiFeo, A., Martignetti, J. A., Alvarez, C. E., Friedman, S. L., Narla, G., Vrabie, R., Bowles, R., Saiman, Y., and Bansal, M. B. (2011) Loss of matrix metalloproteinase-2 amplifies murine toxin-induced liver fibrosis by upregulating collagen\u00a0I expression, Dig. Dis. Sci., 56, 406-416, \nhttps:\/\/doi.org\/10.1007\/s10620-010-1296-0.","journal-title":"Dig. Dis. Sci."},{"key":"2774_CR40","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.bbrc.2011.02.012","volume":"406","author":"I. Onozuka","year":"2011","unstructured":"Onozuka, I., Kakinuma, S., Kamiya, A., Miyoshi, M., Sakamoto, N., Kiyohashi, K., Watanabe, T., Funaoka, Y., Ueyama, M., Nakagawa, M., Koshikawa, N., Seiki, M., Nakauchi, H., and Watanabe, M. (2011) Cholestatic liver fibrosis and toxin-induced fibrosis are exacerbated in matrix metalloproteinase-2 deficient mice, Biochem. Biophys. Res. Commun., 406, 134-140, \nhttps:\/\/doi.org\/10.1016\/j.bbrc.2011.02.012.","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2774_CR41","doi-asserted-by":"publisher","first-page":"23996","DOI":"10.1074\/jbc.M311668200","volume":"279","author":"X. Zhou","year":"2004","unstructured":"Zhou, X., Murphy, F. R., Gehdu, N., Zhang, J., Iredale, J. P., and Benyon, R. C. (2004) Engagement of alphavbeta3 integrin regulates proliferation and apoptosis of hepatic stellate cells, J.\u00a0Biol. Chem., 279, 23996-24006, \nhttps:\/\/doi.org\/10.1074\/jbc.M311668200.","journal-title":"J.\u00a0Biol. Chem."},{"key":"2774_CR42","doi-asserted-by":"publisher","first-page":"5839","DOI":"10.1021\/acs.nanolett.8b02498","volume":"18","author":"P. Melgar-Lesmes","year":"2018","unstructured":"Melgar-Lesmes, P., Luquero, A., Parra-Robert, M., Mora, A., Ribera, J., Edelman, E. R., and Jim\u00e9nez, W. (2018) Graphene-dendrimer nanostars for targeted macrophage overexpression of metalloproteinase\u00a09 and hepatic fibrosis precision therapy, Nano Lett., 18, 5839-5845, \nhttps:\/\/doi.org\/10.1021\/acs.nanolett.8b02498.","journal-title":"Nano Lett."},{"key":"2774_CR43","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.7150\/ijbs.25589","volume":"14","author":"M. Feng","year":"2018","unstructured":"Feng, M., Ding, J., Wang, M., Zhang, J., Zhu, X., and Guan, W. (2018) Kupffer-derived matrix metalloproteinase-9 contributes to liver fibrosis resolution, Int.\u00a0J. Biol. Sci., 14, 1033-1040, \nhttps:\/\/doi.org\/10.7150\/ijbs.25589.","journal-title":"Int.\u00a0J. Biol. Sci."},{"key":"2774_CR44","doi-asserted-by":"publisher","first-page":"5239","DOI":"10.3892\/mmr.2019.10740","volume":"20","author":"Q. Wang","year":"2019","unstructured":"Wang, Q., Liu, X., Zhang, J., Lu, L., Feng, M., and Wang, J. (2019) Dynamic features of liver fibrogenesis and fibrosis resolution in the absence of matrix metalloproteinase\u00a09, Mol. Med. Rep., 20, 5239-5248, \nhttps:\/\/doi.org\/10.3892\/mmr.2019.10740.","journal-title":"Mol. Med. Rep."},{"key":"2774_CR45","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/s1499-3872(14)60261-7","volume":"13","author":"J. Kurzepa","year":"2014","unstructured":"Kurzepa, J., M\u0105dro, A., Czechowska, G., Kurzepa, J., Celi\u0144ski, K., Kazmierak, W., and Slomka, M. (2014) Role of MMP-2 and MMP-9 and their natural inhibitors in liver fibrosis, chronic pancreatitis and non-specific inflammatory bowel diseases, Hepatobiliary Pancreat. Dis. Int., 13, 570-579, \nhttps:\/\/doi.org\/10.1016\/s1499-3872(14)60261-7.","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"2774_CR46","doi-asserted-by":"publisher","first-page":"544","DOI":"10.2741\/1818","volume":"11","author":"C. R. Flannery","year":"2006","unstructured":"Flannery, C. R. (2006) MMPs and ADAMTSs: functional studies, Front. Biosci., 11, 544-569, \nhttps:\/\/doi.org\/10.2741\/1818.","journal-title":"Front. Biosci."},{"key":"2774_CR47","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.2741\/2161","volume":"12","author":"N. T. Le","year":"2007","unstructured":"Le, N. T., Xue, M., Castelnoble, L. A., and Jackson, C.\u00a0J. (2007) The\u00a0dual personalities of matrix metalloproteinases in inflammation, Front. Biosci., 12, 1475-1487, \nhttps:\/\/doi.org\/10.2741\/2161.","journal-title":"Front. Biosci."},{"key":"2774_CR48","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.jhep.2013.12.022","volume":"60","author":"H. Kato","year":"2014","unstructured":"Kato, H., Kuriyama, N., Duarte, S., Clavien, P. A., Busuttil, R. W., and Coito, A.\u00a0J. (2014) MMP-9 deficiency shelters endothelial PECAM-1 expression and enhances regeneration of steatotic livers after ischemia and reperfusion injury, J.\u00a0Hepatol., 60, 1032-1039, \nhttps:\/\/doi.org\/10.1016\/j.jhep.2013.12.022.","journal-title":"J.\u00a0Hepatol."},{"key":"2774_CR49","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.2353\/ajpath.2009.080872","volume":"174","author":"T. Hamada","year":"2009","unstructured":"Hamada, T., Duarte, S., Tsuchihashi, S., Busuttil, R. W., and Coito, A. J. (2009) Inducible nitric oxide synthase deficiency impairs matrix metalloproteinase-9 activity and disrupts leukocyte migration in hepatic ischemia\/reperfusion injury, Am.\u00a0J. Pathol., 174, 2265-2277, \nhttps:\/\/doi.org\/10.2353\/ajpath.2009.080872.","journal-title":"Am.\u00a0J. Pathol."},{"key":"2774_CR50","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1096\/fj.01-0178com","volume":"15","author":"C. Fernandez-Patron","year":"2001","unstructured":"Fernandez-Patron, C., Zouki, C., Whittal, R., Chan, J. S., Davidge, S. T., and Filep, J.\u00a0G. (2001) Matrix metalloproteinases regulate neutrophil-endothelial cell adhesion through generation of endothelin-1[1-32], FASEB\u00a0J., 15, 2230-2240, \nhttps:\/\/doi.org\/10.1096\/fj.01-0178com.","journal-title":"FASEB\u00a0J."},{"key":"2774_CR51","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/370555a0","volume":"370","author":"A. J. Gearing","year":"1994","unstructured":"Gearing, A. J., Beckett, P., Christodoulou, M., Churchill, M., Clements, J., Davidson, A. H., Drummond, A. H., Galloway, W. A., Gilbert, R., Gordon, J. L., Leber, T. M., Mangan, M., Miller, K., Nayee, P., Owen, K., Patel, S., Thomas, W., Wells, G., Wood, L. M., and Woolley, K. (1994) Processing of tumour necrosis factor-alpha precursor by metalloproteinases, Nature, 370, 555-557, \nhttps:\/\/doi.org\/10.1038\/370555a0.","journal-title":"Nature"},{"key":"2774_CR52","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1002\/cphy.c160010","volume":"6","author":"C. Fernandez-Patron","year":"2016","unstructured":"Fernandez-Patron, C., Kassiri, Z., and Leung, D. (2016) Modulation of systemic metabolism by MMP-2: from MMP-2 deficiency in mice to MMP-2 deficiency in patients, Compr. Physiol., 6, 1935-1949, \nhttps:\/\/doi.org\/10.1002\/cphy.c160010.","journal-title":"Compr. Physiol."},{"key":"2774_CR53","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1126\/science.289.5482.1202","volume":"289","author":"G. A. McQuibban","year":"2000","unstructured":"McQuibban, G. A., Gong, J. H., Tam, E. M., McCulloch, C. A., Clark-Lewis, I., and Overall, C. M. (2000) Inflammation dampened by gelatinase\u00a0A cleavage of monocyte chemoattractant protein-3, Science, 289, 1202-1206, \nhttps:\/\/doi.org\/10.1126\/science.289.5482.1202.","journal-title":"Science"},{"key":"2774_CR54","doi-asserted-by":"publisher","first-page":"14657","DOI":"10.1074\/jbc.271.25.14657","volume":"271","author":"A. Ito","year":"1996","unstructured":"Ito, A., Mukaiyama, A., Itoh, Y., Nagase, H., Thogersen, I. B., Enghild, J.\u00a0J., Sasaguri, Y., and Mori, Y. (1996) Degradation of interleukin 1beta by matrix metalloproteinases, J.\u00a0Biol. Chem., 271, 14657-14660, \nhttps:\/\/doi.org\/10.1074\/jbc.271.25.14657.","journal-title":"J.\u00a0Biol. Chem."},{"key":"2774_CR55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0090571","volume":"9","author":"S. R. Calabro","year":"2014","unstructured":"Calabro, S. R., Maczurek, A. E., Morgan, A. J., Tu, T., Wen, V. W., Yee, C., Mridha, A., Lee, M., d\u2019Avigdor, W., Locarnini, S. A., McCaughan, G. W., Warner, F. J., McLennan, S. V., and Shackel, N. A. (2014) Hepatocyte produced matrix metalloproteinases are regulated by CD147 in liver fibrogenesis, PLoS One, 9, e90571, \nhttps:\/\/doi.org\/10.1371\/journal.pone.0090571.","journal-title":"PLoS One"},{"key":"2774_CR56","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.1002\/art.22844","volume":"56","author":"M. Xue","year":"2007","unstructured":"Xue, M., March, L., Sambrook, P. N., and Jackson, C. J. (2007) Differential regulation of matrix metalloproteinase\u00a02 and matrix metalloproteinase\u00a09 by activated protein\u00a0C: relevance to inflammation in rheumatoid arthritis, Arthritis Rheum., 56, 2864-2874, \nhttps:\/\/doi.org\/10.1002\/art.22844.","journal-title":"Arthritis Rheum."},{"key":"2774_CR57","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1042\/CS20030098","volume":"105","author":"R. Lichtinghagen","year":"2003","unstructured":"Lichtinghagen, R., Bahr, M. J., Wehmeier, M., Michels, D., Haberkorn, C. I., Arndt, B., Flemming, P., Manns, M. P., and Boeker, K. H. (2003) Expression and coordinated regulation of matrix metalloproteinases in chronic hepatitis\u00a0C and hepatitis\u00a0C virus-induced liver cirrhosis, Clin. Sci. (Lond), 105, 373-382, \nhttps:\/\/doi.org\/10.1042\/CS20030098.","journal-title":"Clin. Sci. (Lond)"},{"key":"2774_CR58","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1002\/hep.510260620","volume":"26","author":"T. Takahara","year":"1997","unstructured":"Takahara, T., Furui, K., Yata, Y., Jin, B., Zhang, L. P., Nambu, S., Sato, H., Seiki, M., and Watanabe, A. (1997) Dual expression of matrix metalloproteinase-2 and membrane-type 1-matrix metalloproteinase in fibrotic human livers, Hepatology, 26, 1521-1529, \nhttps:\/\/doi.org\/10.1002\/hep.510260620.","journal-title":"Hepatology"},{"key":"2774_CR59","doi-asserted-by":"publisher","first-page":"325","DOI":"10.5604\/12321966.1152088","volume":"22","author":"A. Prystupa","year":"2015","unstructured":"Prystupa, A., Boguszewska-Czubara, A., Bojarska-Junak, A., Toru\u0144-Jurkowska, A., Roli\u0144ski, J., and Za\u0142uska, W. (2015) Activity of MMP-2, MMP-8 and MMP-9 in serum as a marker of progression of alcoholic liver disease in people from Lublin Region, eastern Poland, Ann. Agric. Environ. Med., 22, 325-328, \nhttps:\/\/doi.org\/10.5604\/12321966.1152088.","journal-title":"Ann. Agric. Environ. Med."},{"key":"2774_CR60","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1096\/fj.01-0279fje","volume":"16","author":"R. Cursio","year":"2002","unstructured":"Cursio, R., Mari, B., Louis, K., Rostagno, P., Saint-Paul, M. C., Giudicelli, J., Bottero, V., Anglard, P., Yiotakis, A., Dive, V., Gugenheim, J., and Auberger, P. (2002) Rat liver injury after normothermic ischemia is prevented by a phosphinic matrix metalloproteinase inhibitor, FASEB\u00a0J., 16, 93-95, \nhttps:\/\/doi.org\/10.1096\/fj.01-0279fje.","journal-title":"FASEB\u00a0J."},{"key":"2774_CR61","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/ijc.1635","volume":"97","author":"G. Giannelli","year":"2002","unstructured":"Giannelli, G., Bergamini, C., Marinosci, F., Fransvea, E., Quaranta, M., Lupo, L., Schiraldi, O., and Antonaci, S. (2002) Clinical role of MMP-2\/TIMP-2 imbalance in hepatocellular carcinoma, Int.\u00a0J. Cancer., 97, 425-431, \nhttps:\/\/doi.org\/10.1002\/ijc.1635.","journal-title":"Int.\u00a0J. Cancer."},{"key":"2774_CR62","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1002\/hep.510300431","volume":"30","author":"R. C. Benyon","year":"1999","unstructured":"Benyon, R. C., Hovell, C. J., Da Ga\u00e7a, M., Jones, E. H., Iredale, J.\u00a0P., and Arthur, M.\u00a0J. (1999) Progelatinase\u00a0A is produced and activated by rat hepatic stellate cells and promotes their proliferation, Hepatology, 30, 977-986, \nhttps:\/\/doi.org\/10.1002\/hep.510300431.","journal-title":"Hepatology"},{"key":"2774_CR63","doi-asserted-by":"publisher","first-page":"R71","DOI":"10.1186\/ar1454","volume":"7","author":"W. U. Kim","year":"2005","unstructured":"Kim, W. U., Min, S. Y., Cho, M. L., Hong, K. H., Shin, Y. J., Park, S.\u00a0H., and Cho, C.\u00a0S. (2005) Elevated matrix metalloproteinase-9 in patients with systemic sclerosis, Arthritis Res. Ther., 7, R71-R79, \nhttps:\/\/doi.org\/10.1186\/ar1454.","journal-title":"Arthritis Res. Ther."},{"key":"2774_CR64","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2023.13138","volume":"29","author":"Y. Zhao","year":"2024","unstructured":"Zhao, Y., Yakufu, M., Ma, C., Wang, B., Yang, J., and Hu, J. (2024) Transcriptomics reveal a molecular signature in the progression of nonalcoholic steatohepatitis and identifies PAI\u00a01 and MMP\u00a09 as biomarkers in in\u00a0vivo and in\u00a0vitro studies, Mol. Med. Rep., 29, 15, \nhttps:\/\/doi.org\/10.3892\/mmr.2023.13138.","journal-title":"Mol. Med. Rep."},{"key":"2774_CR65","doi-asserted-by":"publisher","first-page":"5931","DOI":"10.3748\/wjg.v11.i38.5931","volume":"11","author":"M. H. Sun","year":"2005","unstructured":"Sun, M. H., Han, X. C., Jia, M. K., Jiang, W. D., Wang, M., Zhang, H., Han, G., and Jiang, Y. (2005) Expressions of inducible nitric oxide synthase and matrix metalloproteinase-9 and their effects on angiogenesis and progression of hepatocellular carcinoma, World\u00a0J. Gastroenterol., 11, 5931-5937, \nhttps:\/\/doi.org\/10.3748\/wjg.v11.i38.5931.","journal-title":"World\u00a0J. Gastroenterol."},{"key":"2774_CR66","doi-asserted-by":"publisher","first-page":"25062","DOI":"10.1074\/jbc.M109.099655","volume":"285","author":"S. Murthy","year":"2010","unstructured":"Murthy, S., Ryan, A., He, C., Mallampalli, R. K., and Carter, A. B. (2010) Rac1-mediated mitochondrial H2O2 generation regulates MMP-9 gene expression in macrophages via inhibition of SP-1 and AP-1, J.\u00a0Biol. Chem., 285, 25062-25073, \nhttps:\/\/doi.org\/10.1074\/jbc.M109.099655.","journal-title":"J.\u00a0Biol. Chem."},{"key":"2774_CR67","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1002\/hep.21314","volume":"44","author":"E. W. Olle","year":"2006","unstructured":"Olle, E. W., Ren, X., McClintock, S. D., Warner, R. L., Deogracias, M. P., Johnson, K. J., and Colletti, L.\u00a0M. (2006) Matrix metalloproteinase-9 is an important factor in hepatic regeneration after partial hepatectomy in mice, Hepatology, 44, 540-549, \nhttps:\/\/doi.org\/10.1002\/hep.21314.","journal-title":"Hepatology"},{"key":"2774_CR68","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1101\/gad.14.2.163","volume":"14","author":"Q. Yu","year":"2000","unstructured":"Yu, Q., and Stamenkovic, I. (2000) Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis, Genes Dev., 14, 163-176, \nhttps:\/\/doi.org\/10.1101\/gad.14.2.163.","journal-title":"Genes Dev."},{"key":"2774_CR69","doi-asserted-by":"publisher","first-page":"4020","DOI":"10.4049\/jimmunol.173.6.4020","volume":"173","author":"M. Kaviratne","year":"2004","unstructured":"Kaviratne, M., Hesse, M., Leusink, M., Cheever, A. W., Davies, S. J., McKerrow, J. H., Wakefield, L. M., Letterio, J. J., and Wynn, T. A. (2004) IL-13 activates a mechanism of tissue fibrosis that is completely TGF-beta independent, J.\u00a0Immunol., 173, 4020-4029, \nhttps:\/\/doi.org\/10.4049\/jimmunol.173.6.4020.","journal-title":"J.\u00a0Immunol."},{"key":"2774_CR70","doi-asserted-by":"publisher","first-page":"3340","DOI":"10.4049\/jimmunol.161.7.3340","volume":"161","author":"U. Sch\u00f6nbeck","year":"1998","unstructured":"Sch\u00f6nbeck, U., Mach, F., and Libby, P. (1998) Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing, J.\u00a0Immunol., 161, 3340-3346, \nhttps:\/\/doi.org\/10.4049\/jimmunol.161.7.3340.","journal-title":"J.\u00a0Immunol."},{"key":"2774_CR71","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8327945","volume":"2020","author":"J. B. Trojanek","year":"2020","unstructured":"Trojanek, J. B., Micha\u0142kiewicz, J., Grzywa-Czuba, R., Ja\u0144czyk, W., Gackowska, L., Kubiszewska, I., Helmin-Basa, A., Wierzbicka-Ruci\u0144ska, A., Szalecki, M., and Socha, P. (2020) Expression of matrix metalloproteinases and their tissue inhibitors in peripheral blood leukocytes and plasma of children with nonalcoholic fatty liver disease, Mediators Inflamm., 2020, 8327945, \nhttps:\/\/doi.org\/10.1155\/2020\/8327945.","journal-title":"Mediators Inflamm."},{"key":"2774_CR72","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph16193570","volume":"16","author":"V. Kup\u010dov\u00e1","year":"2019","unstructured":"Kup\u010dov\u00e1, V., Fedele\u0161ov\u00e1, M., Bulas, J., Kozmonov\u00e1, P., and Tureck\u00fd, L. (2019) Overview of the pathogenesis, genetic, and non-invasive clinical, biochemical, and scoring methods in the assessment of NAFLD, Int.\u00a0J. Environ. Res. Public Health, 16, 3570, \nhttps:\/\/doi.org\/10.3390\/ijerph16193570.","journal-title":"Int.\u00a0J. Environ. Res. Public Health"},{"key":"2774_CR73","doi-asserted-by":"publisher","first-page":"62","DOI":"10.17116\/terarkh2016881262-68","volume":"88","author":"M. A. Livzan","year":"2016","unstructured":"Livzan, M. A., Akhmedov, V. A., Krolevets, T. S., Gaus, O. V., and Cherkashenko, N. A. (2016) The informative value of non-invasive liver fibrosis markers in patients with nonalcoholic fatty liver disease, Ter. Arkh., 88, 62-68, \nhttps:\/\/doi.org\/10.17116\/terarkh2016881262-68.","journal-title":"Ter. Arkh."},{"key":"2774_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.113869","volume":"176","author":"S. Kumar","year":"2021","unstructured":"Kumar, S., Duan, Q., Wu, R., Harris, E.\u00a0N., and Su, Q. (2021) Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis, Adv. Drug Deliv. Rev., 176, 113869, \nhttps:\/\/doi.org\/10.1016\/j.addr.2021.113869.","journal-title":"Adv. Drug Deliv. Rev."},{"key":"2774_CR75","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1042\/CS20190068","volume":"133","author":"M. B. Afonso","year":"2019","unstructured":"Afonso, M. B., Castro, R. E., and Rodrigues, C. M. P. (2019) Processes exacerbating apoptosis in non-alcoholic steatohepatitis, Clin. Sci. (Lond), 133, 2245-2264, \nhttps:\/\/doi.org\/10.1042\/CS20190068.","journal-title":"Clin. Sci. (Lond)"},{"key":"2774_CR76","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.jhep.2022.06.012","volume":"77","author":"M. Peiseler","year":"2022","unstructured":"Peiseler, M., Schwabe, R., Hampe, J., Kubes, P., Heikenw\u00e4lder, M., and Tacke, F. (2022) Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease\u00a0\u2013 novel insights into cellular communication circuits, J.\u00a0Hepatol., 77, 1136-1160, \nhttps:\/\/doi.org\/10.1016\/j.jhep.2022.06.012.","journal-title":"J.\u00a0Hepatol."},{"key":"2774_CR77","doi-asserted-by":"publisher","first-page":"52","DOI":"10.17116\/terarkh201789252-58","volume":"89","author":"I. V. Kurbatova","year":"2017","unstructured":"Kurbatova, I. V., and Dudanova, O. P. (2017) Features of a necrotic and inflammatory process in different forms of nonalcoholic fatty liver disease, Ter. Arkh, 89, 52-58, \nhttps:\/\/doi.org\/10.17116\/terarkh201789252-58.","journal-title":"Ter. Arkh"},{"key":"2774_CR78","doi-asserted-by":"publisher","first-page":"585","DOI":"10.47056\/0365-9615-2022-174-11-585-591","volume":"174","author":"I. V. Kurbatova","year":"2022","unstructured":"Kurbatova, I. V., Topchieva, L. V., Dudanova, O. P., and Shipovskaya, A.\u00a0A. (2022) The role of the soluble interleukin-6 receptor in the progression of nonalcoholic fatty liver disease [in Russian], Bull. Exp. Biol. Med., 174, 585-591, \nhttps:\/\/doi.org\/10.47056\/0365-9615-2022-174-11-585-591.","journal-title":"Bull. Exp. Biol. Med."},{"key":"2774_CR79","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0051701","volume":"8","author":"Y. Q. Li","year":"2013","unstructured":"Li, Y. Q., Yan, J. P., Xu, W. L., Wang, H., Xia, Y. J., Wang, H. J., Zhu, Y.\u00a0Y., and Huang, X.\u00a0J. (2013) ADAM17 mediates MMP9 expression in lung epithelial cells, PLoS One, 8, e51701, \nhttps:\/\/doi.org\/10.1371\/journal.pone.0051701.","journal-title":"PLoS One"},{"key":"2774_CR80","doi-asserted-by":"publisher","DOI":"10.3390\/cells8101226","volume":"8","author":"D. Schmidt-Arras","year":"2019","unstructured":"Schmidt-Arras, D., and Rose-John, S. (2019) Regulation of fibrotic processes in the liver by ADAM proteases, Cells, 8, 1226, \nhttps:\/\/doi.org\/10.3390\/cells8101226.","journal-title":"Cells"},{"key":"2774_CR81","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1007\/s00109-014-1170-1","volume":"92","author":"A. Wree","year":"2014","unstructured":"Wree, A., McGeough, M. D., Pe\u00f1a, C. A., Schlattjan, M., Li, H., Inzaugarat, M. E., Messer, K., Canbay, A., Hoffman, H. M., and Feldstein, A. E. (2014) NLRP3 inflammasome activation is required for fibrosis development in NAFLD, J.\u00a0Mol. Med. (Berl), 92, 1069-1082, \nhttps:\/\/doi.org\/10.1007\/s00109-014-1170-1.","journal-title":"J.\u00a0Mol. Med. (Berl)"},{"key":"2774_CR82","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","volume":"94","author":"E. M. Brunt","year":"1999","unstructured":"Brunt, E. M., Janney, C. G., Di Bisceglie, A. M., Neuschwander-Tetri, B.\u00a0A., and Bacon, B.\u00a0R. (1999) Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions, Am.\u00a0J. Gastroenterol., 94, 2467-2474, \nhttps:\/\/doi.org\/10.1111\/j.1572-0241.1999.01377.x.","journal-title":"Am.\u00a0J. Gastroenterol."},{"key":"2774_CR83","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"W. T. Friedewald","year":"1972","unstructured":"Friedewald, W. T., Levy, R. I., and Fredrickson, D. S. (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge, Clin. Chem., 18, 499-502, \nhttps:\/\/doi.org\/10.1093\/clinchem\/18.6.499.","journal-title":"Clin. Chem."},{"key":"2774_CR84","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"R. K. Sterling","year":"2006","unstructured":"Sterling, R. K., Lissen, E., Clumeck, N., Sola, R., Correa, M. C., Montaner, J., Sulkowski, M., Torriani, F. J., Dieterich, D. T., Thomas, D. L., Messinger, D., Nelson, M., and APRICOT Clinical Investigators (2006) Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection, Hepatology, 43, 1317-1325, \nhttps:\/\/doi.org\/10.1002\/hep.21178.","journal-title":"Hepatology"},{"key":"2774_CR85","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","volume":"7","author":"A. G. Shah","year":"2009","unstructured":"Shah, A. G., Lydecker, A., Murray, K., Tetri, B. N., Contos, M. J., and Sanyal, A.\u00a0J., and Nash Clinical Research Network (2009) Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease, Clin. Gastroenterol. Hepatol., 7, 1104-1112, \nhttps:\/\/doi.org\/10.1016\/j.cgh.2009.05.033.","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"2774_CR86","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1053\/jhep.2003.50346","volume":"38","author":"C. T. Wai","year":"2003","unstructured":"Wai, C. T., Greenson, J. K., Fontana, R. J., Kalbfleisch, J. D., Marrero, J. A., Conjeevaram, H. S., and Lok, A.\u00a0S. (2003) A\u00a0simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis\u00a0C, Hepatology, 38, 518-526, \nhttps:\/\/doi.org\/10.1053\/jhep.2003.50346.","journal-title":"Hepatology"},{"key":"2774_CR87","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/S1665-2681(19)31836-8","volume":"7","author":"A. Loaeza-del-Castillo","year":"2008","unstructured":"Loaeza-del-Castillo, A., Paz-Pineda, F., Oviedo-C\u00e1rdenas, E., S\u00e1nchez-Avila, F., and Vargas-Vor\u00e1ckov\u00e1, F. (2008) AST to platelet ratio index (APRI) for the noninvasive evaluation of liver fibrosis, Ann. Hepatol., 7, 350-357, \nhttps:\/\/doi.org\/10.1016\/S1665-2681(19)31836-8.","journal-title":"Ann. Hepatol."},{"key":"2774_CR88","doi-asserted-by":"publisher","first-page":"82","DOI":"10.17116\/profmed20192202182","volume":"22","author":"O. M. Drapkina","year":"2019","unstructured":"Drapkina, O. M., Shepel, R. N., Yakovenko, E. P., and Zyatenkova, E. V. (2019) Non-invasive methods for detection of progressive fibrosis in patients with nonalcoholic fat liver disease, Profilakt. Meditsina, 22, 82-88, \nhttps:\/\/doi.org\/10.17116\/profmed20192202182.","journal-title":"Profilakt. Meditsina"},{"key":"2774_CR89","doi-asserted-by":"publisher","unstructured":"ACK Lysis Buffer (2014) Cold Spring Harb. Protoc., \nhttps:\/\/doi.org\/10.1101\/pdb.rec083295.","DOI":"10.1101\/pdb.rec083295"},{"key":"2774_CR90","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"K. J. Livak","year":"2001","unstructured":"Livak, K. J., and Schmittgen, T. D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2013\u2206\u2206CT method, Methods, 25, 402-408, \nhttps:\/\/doi.org\/10.1006\/meth.2001.1262.","journal-title":"Methods"},{"key":"2774_CR91","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::aid-cncr2820030106>3.0.co;2-3","volume":"3","author":"W. J. Youden","year":"1950","unstructured":"Youden, W. J. (1950) Index for rating diagnostic tests, Cancer, 3, 32-35, \nhttps:\/\/doi.org\/10.1002\/1097-0142(1950)3:1<32::aid-cncr2820030106>3.0.co;2-3.","journal-title":"Cancer"},{"key":"2774_CR92","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/clinchem\/39.4.561","volume":"39","author":"M. H. Zweig","year":"1993","unstructured":"Zweig, M. H., and Campbell, G. (1993) Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine, Clin. Chem., 39, 561-577, \nhttps:\/\/doi.org\/10.1093\/clinchem\/39.4.561.","journal-title":"Clin. Chem."},{"key":"2774_CR93","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.hbpd.2018.08.008","volume":"18","author":"J. J. Ren","year":"2019","unstructured":"Ren, J. J., Huang, T. J., Zhang, Q. Q., Zhang, H. Y., Guo, X. H., Fan, H. Q., Li, R. K., and Liu, L. X. (2019) Insulin-like growth factor binding protein related protein\u00a01 knockdown attenuates hepatic fibrosis via the regulation of MMPs\/TIMPs in mice, Hepatobiliary Pancreat. Dis. Int., 18, 38-47, \nhttps:\/\/doi.org\/10.1016\/j.hbpd.2018.08.008.","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"2774_CR94","doi-asserted-by":"publisher","first-page":"4773","DOI":"10.3748\/wjg.v16.i38.4773","volume":"16","author":"G. Tarantino","year":"2010","unstructured":"Tarantino, G., Savastano, S., and Colao, A. (2010) Hepatic steatosis, low-grade chronic inflammation and hormone\/growth factor\/adipokine imbalance, World\u00a0J. Gastroenterol., 16, 4773-4783, \nhttps:\/\/doi.org\/10.3748\/wjg.v16.i38.4773.","journal-title":"World\u00a0J. Gastroenterol."},{"key":"2774_CR95","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-00312-6","volume":"5","author":"H. Yu","year":"2020","unstructured":"Yu, H., Lin, L., Zhang, Z., Zhang, H., and Hu, H. (2020) Targeting NF-\u03baB pathway for the therapy of diseases: mechanism and clinical study, Signal Transduct. Target Ther., 5, 209, \nhttps:\/\/doi.org\/10.1038\/s41392-020-00312-6.","journal-title":"Signal Transduct. Target Ther."},{"key":"2774_CR96","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1152\/ajpcell.00379.2020","volume":"320","author":"T. Kawai","year":"2021","unstructured":"Kawai, T., Autieri, M. V., and Scalia, R. (2021) Adipose tissue inflammation and metabolic dysfunction in obesity, Am.\u00a0J. Physiol. Cell Physiol., 320, 375-391, \nhttps:\/\/doi.org\/10.1152\/ajpcell.00379.2020.","journal-title":"Am.\u00a0J. Physiol. Cell Physiol."},{"key":"2774_CR97","doi-asserted-by":"publisher","DOI":"10.3390\/cells11193001","volume":"11","author":"H. Li","year":"2022","unstructured":"Li, H., Meng, Y., He, S., Tan, X., Zhang, Y., Zhang, X., Wang, L., and Zheng, W. (2022) Macrophages, chronic inflammation, and insulin resistance, Cells, 11, 3001, \nhttps:\/\/doi.org\/10.3390\/cells11193001.","journal-title":"Cells"},{"key":"2774_CR98","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1146\/annurev-pathmechdis-032521-102529","volume":"17","author":"M. De Carvalho Ribeiro","year":"2022","unstructured":"De Carvalho Ribeiro, M., and Szabo, G. (2022) Role of the inflammasome in liver disease, Annu. Rev. Pathol., 17, 345-365, \nhttps:\/\/doi.org\/10.1146\/annurev-pathmechdis-032521-102529.","journal-title":"Annu. Rev. Pathol."},{"key":"2774_CR99","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/hep.24341","volume":"54","author":"T. Csak","year":"2011","unstructured":"Csak, T., Ganz, M., Pespisa, J., Kodys, K., Dolganiuc, A., and Szabo, G. (2011) Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells, Hepatology, 54, 133-144, \nhttps:\/\/doi.org\/10.1002\/hep.24341.","journal-title":"Hepatology"},{"key":"2774_CR100","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/MEG.0000000000001240","volume":"31","author":"Y. Yilmaz","year":"2019","unstructured":"Yilmaz, Y. and Eren, F. (2019) Serum biomarkers of fibrosis and extracellular matrix remodeling in patients with nonalcoholic fatty liver disease: association with liver histology, Eur.\u00a0J. Gastroenterol. Hepatol., 31, 43-46, \nhttps:\/\/doi.org\/10.1097\/MEG.0000000000001240.","journal-title":"Eur.\u00a0J. Gastroenterol. Hepatol."},{"key":"2774_CR101","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-022-01764-1","volume":"22","author":"J. Wagner","year":"2023","unstructured":"Wagner, J., Kumar, Y., Lautenbach, A., von Kroge, P., Wolter, S., Mann, O., Izbicki, J., Gagliani, N., and Dupr\u00e9e, A. (2023) Fatty acid-binding protein-4 (FABP4) and matrix metalloproteinase-9 (MMP9) as predictive values for nonalcoholic steatohepatitis (NASH), Lipids Health Dis., 22, 1, \nhttps:\/\/doi.org\/10.1186\/s12944-022-01764-1.","journal-title":"Lipids Health Dis."},{"key":"2774_CR102","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0260313","volume":"16","author":"A. Goyale","year":"2021","unstructured":"Goyale, A., Jain, A., Smith, C., Papatheodoridi, M., Misas, M. G., Roccarina, D., Prat, L.\u00a0I., Mikhailidis, D.\u00a0P., Nair, D., and Tsochatzis, E. (2021) Assessment of non-alcoholic fatty liver disease (NAFLD) severity with novel serum-based markers: A\u00a0pilot study, PLoS One, 16, e0260313, \nhttps:\/\/doi.org\/10.1371\/journal.pone.0260313.","journal-title":"PLoS One"},{"key":"2774_CR103","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.it.2011.05.005","volume":"32","author":"J. Scheller","year":"2011","unstructured":"Scheller, J., Chalaris, A., Garbers, C., and Rose-John, S. (2011) ADAM17: a molecular switch to control inflammation and tissue regeneration, Trends Immunol., 32, 380-387, \nhttps:\/\/doi.org\/10.1016\/j.it.2011.05.005.","journal-title":"Trends Immunol."},{"key":"2774_CR104","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.31557\/APJCP.2021.22.5.1623","volume":"22","author":"Y. An","year":"2021","unstructured":"An, Y., Zhao, J., Zhang, Y., Wu, W., Hu, J., Hao, H., Qiao, Y., Tao, Y., and An, L. (2021) Rosmarinic acid induces proliferation suppression of hepatoma cells associated with NF-\u03baB signaling pathway, Asian Pac. J. Cancer Prev., 22, 1623-1632, \nhttps:\/\/doi.org\/10.31557\/APJCP.2021.22.5.1623.","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"2774_CR105","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1111\/his.13665","volume":"73","author":"I. D. Munsterman","year":"2018","unstructured":"Munsterman, I. D., Kendall, T. J., Khelil, N., Popa, M., Lomme, R., Drenth, J. P. H., and Tjwa, E. T. T. L. (2018) Extracellular matrix components indicate remodelling activity in different fibrosis stages of human non-alcoholic fatty liver disease, Histopathology, 73, 612-621, \nhttps:\/\/doi.org\/10.1111\/his.13665.","journal-title":"Histopathology"},{"key":"2774_CR106","doi-asserted-by":"publisher","DOI":"10.1515\/hmbci-2018-0037","volume":"41","author":"M. Barchuk","year":"2018","unstructured":"Barchuk, M., Schreier, L., Berg, G., and Miksztowicz, V. (2018) Metalloproteinases in non-alcoholic fatty liver disease and their behavior in liver fibrosis, Horm. Mol. Biol. Clin. Invest., 41, 20180037, \nhttps:\/\/doi.org\/10.1515\/hmbci-2018-0037.","journal-title":"Horm. Mol. Biol. Clin. Invest."}],"container-title":["Biochemistry (Moscow)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S0006297924110130.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1134\/S0006297924110130","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S0006297924110130.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:23:26Z","timestamp":1773620606000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1134\/S0006297924110130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":106,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["2774"],"URL":"https:\/\/doi.org\/10.1134\/s0006297924110130","relation":{},"ISSN":["0006-2979","1608-3040"],"issn-type":[{"value":"0006-2979","type":"print"},{"value":"1608-3040","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"2 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The authors of this work declare that they have no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}}]}}